Benign neoplasm: Connective and other soft tissue of abdomen

CD2_BENIGN_CONNSOFT_ABD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D21.4& Hospital discharge: ICD-9 — 2155 Cause of death: ICD-10 — D21.4& Cause of death: ICD-9 — 2155 2 out of 7 registries used, show all original rules.	101
4. Check minimum number of events None	101
5. Include endpoints None	101
6. Filter based on genotype QC (FinnGen only)	101

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D21
Name in latin: Neoplasma benignum textus connectivi abdominis

NAME	CD2_BENIGN_CONNSOFT_ABD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D214
HD_ICD_9	2155
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D214
COD_ICD_9	2155
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Connective and other soft tissue of abdomen based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Connective and other soft tissue of abdomen

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	814	549	263
Only index persons	728	504	224
Unadjusted period prevalence (%)
Whole population	0.01	0.02	0.01
Only index persons	0.02	0.02	0.01
Median age at first event (years)
Whole population	46.06	43.94	50.31
Only index persons	44.26	42.22	48.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	101	71	30
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	46.45	41.21	58.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
95: Matched controls
951

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D21.4

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of abdomen

+∞

94.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

12.1

13.5

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

+∞

8.5

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

24.6

8.2

2155X

ICD-9 Finland

Other benign neoplasm of connective and other soft tissue, Abdomen[ABDOMENIN BENIGNI PEHMYTKUDOSKASVAIN,TARK MÄÄRITTEL]

+∞

7.4

6141

FHL

Exploration or removal of a local change in the abdominal wall (umbilical cord, tumor, hematoma, endometrioma)

+∞

6.3

2155A

ICD-9 Finland

Other benign neoplasm of connective and other soft tissue, Abdomen[ABDOMENIN BENIGNI PEHMYTKUDOSKASVAIN,SIDEKUDOSPERÄI]

+∞

6.3

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

16.4

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

145

2.77

4.95

3.9

3.1

91.7

73.6

ng/l

0.12

107

(3013707) Erythrocyte sedimentation rate by Westergren method

623

2.52

3.45

3.7

4.3

14.1

11.3

mm/h

0.84

571

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.56

3.24

1.7

1.6

—

(3018418) pH of Serum or Plasma

248

2.10

3.15

2.9

4.0

7.4

—

(3012544) pH of Venous blood

2.72

3.07

2.2

3.5

—

(3000991) Gas panel - Venous blood

2.81

2.94

9.8

7.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

844

3.77

2.90

20.2

13.2

23.8

20.9

mg/l

0.35

660

(3002256) Pathology report gross observation

2.41

2.78

1.2

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

134

2.15

2.56

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.34

2.53

1.7

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

276

1.89

2.44

3.2

2.0

—

(3023368) Bacteria identified in Blood by Culture

197

1.91

2.23

6.4

3.9

—

(3042936) Bacteria identified in Isolate by Culture

111

2.13

2.21

3.2

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

391

1.75

2.01

8.2

6.7

1.2

mmol/l

0.50

329

(3000492) Spirometry study

2.42

2.00

1.5

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

596

1.81

1.89

4.1

4.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

879

2.86

1.79

23.6

15.4

74.4

73.9

umol/l

0.08

879

(3002582) Erythrocytes [#/volume] in Urine

245

1.73

1.77

3.4

3.0

31.7

293.4

e6/l

0.50

188

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

169

1.82

1.76

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

366

1.66

1.70

6.9

5.6

1.2

mmol/l

0.09

334

(3009261) Glucose [Presence] in Urine by Test strip

424

1.65

1.68

4.1

3.7

0.0

estimate

—

(40768804) Tissue Pathology biopsy report

349

1.65

2.3

2.0

—

(3030467) Casts [#/volume] in Urine by Automated count

217

1.69

1.58

3.6

2.9

0.5

0.4

e6/l

0.19

158

(3021601) Nitrite [Presence] in Urine by Test strip

419

1.62

1.57

6.0

4.9

0.0

estimate

—

(3020682) Albumin/Creatinine [Ratio] in Urine

235

1.67

1.56

3.0

3.8

13.7

8.9

mg/mmol

0.15

151

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

209

1.70

1.56

3.4

1.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.97

1.53

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.97

1.53

1.7

1.4

—

(3015736) pH of Urine

327

1.61

1.51

3.8

3.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

194

1.69

1.49

3.4

3.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

543

1.62

1.47

3.2

3.4

—

(3044889) 12 lead EKG panel

575

1.63

1.45

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

496

1.58

1.40

9.0

9.1

4.3

4.2

e9/l

0.05

439

(3019150) Specific gravity of Urine by Refractometry

189

1.67

1.39

3.8

3.5

1.0

kg/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.25

1.39

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.90

1.39

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.25

1.38

1.4

—

(36304419) Bacteria [Presence] in Urine

217

1.62

1.34

3.5

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

124

1.76

1.33

2.9

2.5

2.2

3.0

e6/l

—

(3034770) Mitochondria Ab [Titer] in Serum

2.59

1.32

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

412

1.54

1.31

5.1

3.8

—

(3018095) Leukocytes [#/volume] in Urine

290

1.56

1.30

4.1

3.5

185.3

59.1

e6/l

0.63

203

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

150

1.69

1.29

1.2

1.3

1.0

8.8

u/ml

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

282

1.56

1.28

3.6

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.49

1.26

1.0

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

204

1.59

1.22

1.9

2.6

355.3

6268.3

umol/l

1.06

173

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.08

1.15

1.4

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

155

1.63

1.14

1.1

1.3

10.8

30.3

iu/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

421

1.48

1.14

4.2

3.6

0.0

estimate

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.78

1.11

3.1

4.1

283.0

234.9

u/l

0.54

(3032080) INR in Blood by Coagulation assay

319

1.48

1.08

4.5

8.3

1.2

1.1

inr

—

101

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.20

1.08

7.3

6.8

22.1

26.3

mmol/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.20

1.08

1.4

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

132

1.64

1.07

3.0

2.3

0.7

1.3

e6/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

814

1.79

1.06

4.5

4.4

4.5

4.7

mmol/l

0.82

754

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

769

1.66

1.05

4.2

3.9

1.3

mmol/l

0.21

699

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

827

1.81

1.04

5.0

4.8

2.6

2.8

mmol/l

0.87

761

(40768797) Stomach Pathology biopsy report

125

1.64

1.03

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

771

1.65

1.01

6.2

5.4

40.3

39.4

mmol/mol

0.35

723

(3037121) Protein [Mass/volume] in Urine

0.00

0.99

0.0

3.6

—

0.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.99

0.0

2.9

—

(3021589) Normoblasts [#/volume] in Blood

352

1.44

0.99

8.7

9.2

0.0

e9/l

0.50

284

(3013115) Eosinophils [#/volume] in Blood

439

1.44

0.99

6.1

5.7

0.2

e9/l

0.03

393

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.99

0.0

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

807

1.70

0.98

4.4

4.3

1.5

mmol/l

0.47

742

(40758558) Short blood count panel - Blood

214

1.50

0.98

6.5

7.2

—

(3012516) Albumin [Mass/volume] in Urine

223

1.49

0.98

2.7

3.1

80.7

68.7

mg/l

0.06

147

(3000494) Fungus identified in Specimen by Culture

103

1.66

0.94

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.21

0.93

1.8

1.5

—

(40761511) CBC panel - Blood by Automated count

874

1.81

0.91

17.4

12.6

—

(3006315) Basophils [#/volume] in Blood

424

1.41

0.91

5.9

5.5

0.0

e9/l

0.07

373

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

800

1.63

0.90

4.5

5.9

mmol/l

0.04

739

(42870588) Differential panel, method unspecified - Blood

275

1.42

0.85

5.3

5.1

—

(3019198) Lymphocytes [#/volume] in Blood

438

1.39

0.84

5.8

5.5

2.1

2.0

e9/l

0.09

392

(3009542) Hematocrit [Volume Fraction] of Blood

749

1.50

0.82

25.0

14.4

36.5

39.7

1.88

560

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

571

1.39

0.80

3.3

3.0

67.0

48.0

u/l

0.94

536

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

151

1.49

0.79

1.8

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

134

1.51

0.78

6.2

4.9

23.8

20.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.77

0.78

1.6

1.5

1.3

g/l

—

(3029937) Albumin [Presence] in Urine by Test strip

233

1.41

0.77

3.7

3.8

0.0

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

170

1.46

0.76

1.9

—

(3001604) Monocytes [#/volume] in Blood

424

1.35

0.75

6.0

5.5

0.6

e9/l

0.30

371

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.90

0.75

20.7

7.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.90

0.75

2.7

2.5

0.6

0.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2.05

0.74

1.4

1.2

18.3

10.9

u/l

—

(3037522) Nuclear Ab [Titer] in Serum

119

1.52

0.73

1.3

1.5

176.0

394.1

titre

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.76

0.71

2.7

2.5

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

330

1.35

0.71

4.6

3.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.63

0.66

2.7

3.5

127.7

129.6

g/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.76

0.64

2.2

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

794

1.45

0.62

19.6

12.3

83.3

82.7

ml/min/173m2

0.08

630

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

159

1.40

0.62

1.2

1.4

—

(3019060) Gas panel - Arterial blood

1.58

0.61

1.8

4.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.50

0.60

1.8

2.9

9.7

7.6

umol/l

0.20

(3003694) ABO and Rh group [Type] in Blood

246

0.72

0.58

1.7

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.58

0.57

4.7

4.4

4.7

pmol/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.58

0.57

3.6

2.1

5.1

5.0

ug/l

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.66

0.56

3.8

3.4

38.9

46.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.57

0.54

3.5

3.7

25.4

24.9

mmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

333

1.28

0.52

2.2

2.0

78.4

97.1

pmol/l

0.83

169

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.49

0.52

1.3

2.2

342.4

362.8

nmol/l

0.12

(3026008) Bacteria identified in Urine by Culture

239

1.30

0.50

3.3

2.9

—

(4035726)

1.50

0.50

1.5

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.50

0.50

2.5

2.2

0.2

g/l

0.24

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.64

0.43

1.0

1.2

—

(3025941) Bacteria identified in Stool by Culture

1.41

0.43

1.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.41

0.0

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.40

0.0

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

199

1.27

0.40

1.5

1.2

0.7

0.8

u/ml

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(40761535) Cells panel - Urine sediment

1.33

0.38

4.4

3.1

—

(40761536) Microorganisms panel - Urine sediment

1.31

0.38

2.7

4.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

278

1.22

0.36

2.8

2.5

63.9

54.2

u/l

0.75

256

(3015377) Calcium [Moles/volume] in Serum or Plasma

288

1.22

0.35

3.9

3.7

2.4

mmol/l

0.02

251

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.71

0.32

1.6

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.37

0.32

1.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

103

1.30

0.30

1.5

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

104

1.29

0.28

2.2

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

104

1.29

0.28

10.0

8.5

—

(36660697) Celiac disease serology panel - Serum

1.22

0.26

1.3

1.1

—

(40768443) Skin Pathology biopsy report

1.37

0.24

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.72

0.23

1.7

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.26

0.23

1.4

1.6

—

(3000330) Specific gravity of Urine by Test strip

1.20

0.22

6.0

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

207

0.84

0.21

1.8

1.4

18.7

21.6

nmol/l

0.50

170

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

2.0

—

612.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.21

0.0

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.21

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

5.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

2.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.24

0.20

1.7

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.20

0.0

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.20

0.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.20

0.0

1.4

—

(3025159) Blasts/100 leukocytes in Blood

0.76

0.17

2.6

4.3

—

0.6

—

(4010399)

1.14

0.16

1.3

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.17

0.16

2.4

3.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

107

0.83

0.13

1.7

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

308

1.11

0.13

3.3

4.1

26.5

44.3

ng/l

0.46

206

(3004588) Protein electrophoresis panel - Serum or Plasma

1.12

0.10

2.8

1.6

—

(3009343) pH of Capillary blood

1.07

0.09

1.6

3.2

—

7.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.08

0.09

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.08

0.09

1.7

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.04

0.08

2.2

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.04

0.08

2.8

1.9

61.2

67.3

g/l

—

(3022621) pH of Urine by Test strip

1.05

0.08

2.0

2.3

—

(1761868) Lipid panel - Serum or Plasma

285

1.07

0.07

3.8

2.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

197

1.08

0.07

4.1

4.8

—

(3013512) EKG study

233

0.93

0.06

3.7

3.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

243

1.04

0.01

4.7

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

175

1.03

0.00

1.6

1.3

2.5

g/l

0.01

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.93

0.00

1.1

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(4281824)

0.00

0.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.96

0.00

1.3

1.7

—

(3000012) Reticulocyte production index

0.00

0.0

1.0

—

(44806071)

0.00

0.0

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.84

0.00

1.4

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

669.6

—

(4027681)

0.00

0.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

9.2

—

999.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.1

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

1.6

—

(3022145) Colonoscopy Study observation

0.98

0.00

1.2

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

111.0

—

(3028433) Virus identified in Specimen by Culture

0.00

0.0

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

10.8

—

1610.4

—

(4146454)

0.00

0.0

3.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

146.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.7

—

(3024263) Appearance of Synovial fluid

0.00

0.0

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.0

10.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

0.90

0.00

2.5

4.0

—

0.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

4.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.3

—

38.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3019225) pH of Specimen

0.96

0.00

2.0

4.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.7

—

(4024509)

0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CONNSOFT_ABD and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CONNSOFT_ABD	1.671 [1.13, 2.47]	0.01
Birth year	0.997 [0.99, 1.01]	0.464

During the follow-up period (1.1.1998 — 31.12.2019), 55 out of 382 females with CD2_BENIGN_CONNSOFT_ABD died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CONNSOFT_ABD.

N-year risk	Females	Males
1	0.156%	No data
5	1.052%	No data
10	2.632%	No data
15	4.982%	No data
20	8.626%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CONNSOFT_ABD – Benign neoplasm: Connective and other soft tissue of abdomen

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Connective and other soft tissue of abdomen

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints